Plain-English translation of NCT07347925 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study looks at people hospitalized with heart failure and a weakened heart pump to understand whether taking a medication called an angiotensin receptor-neprilysin inhibitor (ARNI) before coming to the hospital affects their short-term health outcomes. Researchers will compare two groups: those who were already taking the medication at home and those who were not. The study will track heart-related events, kidney function, and length of hospital stay to see if the medication makes a difference.
Doctors want to understand how this medication works in real-world situations when patients arrive at the hospital with acute heart failure. Learning whether people who were already on this treatment have better outcomes could help guide treatment decisions for future patients.
You likely qualify if…
You likely don't qualify if…
You would not need to take any new medication or undergo special procedures. Researchers will review your medical records during your hospital stay to collect information about your heart and kidney function, any heart-related events, and how long you stay in the hospital. Some participants may be contacted for a brief follow-up period after you leave the hospital. The study simply observes and compares outcomes between people already taking the medication and those who are not.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Egypt
Enrollment target
~140 participants
Started
January 2026
Primary completion
April 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.